Clinical Trials Directory

Trials / Terminated

TerminatedNCT00218036

Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8

Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
54 (actual)
Sponsor
The University of Texas Health Science Center, Houston · Academic / Other
Sex
All
Age
22 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to examine two medications, modafinil and citalopram, in the treatment of cocaine dependent individuals who are maintained on methadone.

Detailed description

This is a 24-week, randomized, double-blind, placebo-controlled study examining two doses of modafinil (200 and 400 mg) and citalopram (20 and 40 mg) in the treatment of methadone maintained cocaine dependent individuals. Participants will first be given methadone to determine its tolerated and effective doses. Most participants will be able to reach a stable dose of methadone within 7 to 10 days of methadone initiation. When 80% of the projected dose of methadone has been achieved, participants will begin the medication regimen of modafinil or citalopram. Modafinil will be given over a 7-day period. Dosing of modafinil will begin at 200 mg and, depending on the individual, may increase to 400 mg. Citalopram will be given in increasing doses, starting at 20 mg and increasing to 40mg.

Conditions

Interventions

TypeNameDescription
DRUGModafinil 200mg10 day medication run-up to Modafinil 200mg while subject is methadone maintained at 1/2 mg/kg. On full dose for 12 weeks and then titrated down for 10 days.
DRUGModafinil 400mg10 day medication run-up to 400mg of Modafinil while subject is methadone maintained at 1.2 mg/kg. On full dose for 12 weeks and then titrated down for 10 days.
DRUGCitalopram 20mg10 day run-up to Citalopram 20mg while subject is methadone maintained at 1.2mg/kg. On full dose for 12 weeks and then titrated down for 10 days.
DRUGCitalopram 40mg10 day medication run-up to Citalopram 40 mg while subjects are methadone maintained (1.2 mg/kg). On full dose for 12 weeks and then titrated down for 10 days.
DRUGPlaceboPlacebo while patient is methadone maintained on standard dose of 1.2 mg/kg

Timeline

Start date
2006-07-01
Primary completion
2010-02-01
Completion
2010-02-01
First posted
2005-09-22
Last updated
2018-11-16
Results posted
2018-11-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00218036. Inclusion in this directory is not an endorsement.